15% Patients lost an average of 15% of their body weight in ~1 year.* *In a 68-week double-blind trial studying once-weekly semaglutide injections (2.4 mg) in 1,961 patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15%, when paired with diet and exercise changes
Special Populations Patients with diabetic gastroparesis
ou'll reduce your risk of many chronic illnesses, enhance your vigor and enjoyment of life, slightly slow the tick of the aging clock and perhaps more importantly, be stronger, sexier and more vigorous as you age
The fat-loss driver and the tissue-repair driver, run together, produce a body transformation that addresses more variables than fat loss alone
Furthermore, the long-term safety of brodalumab remains to be determined in the phase three study